ArticlePostepy dermatologii i alergologii2017
Demographic characteristics, aetiology, and assessment of treatment options in leukocytoclastic vasculitis.
Article in Postepy dermatologii i alergologii, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 17 citations in OpenAlex.
- Demographic and clinicopathological features of cutaneous vasculitis.Archives of dermatological research · 2025Article
- Aetiology of Vascular Purpura in a Single Centre Experience: Contribution of Clinical and Paraclinical Data.Mediterranean journal of rheumatology · 2024Article
- Cephalexin-Induced Leukocytoclastic Vasculitis.Cureus · 2022Article
- Life-threatening manifestation of cutaneous leukocytoclastic vasculitis.Postepy dermatologii i alergologii · 2021Article
- Article
- Early diagnosis and treatment of Leukocytoclastic Vasculitis: case report.Jornal vascular brasileiro · 2020Article
- Ceftriaxone-induced leucocytoclastic vasculitis.BMJ case reports · 2019Article
- Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism.Respiratory medicine case reports · 2019Article
- A case of leukocytoclastic vasculitis associated with anti-tumor necrosis factor therapy.Postepy dermatologii i alergologii · 2018Article
- Systemic disease in leukocytoclastic vasculitis: a focus on direct immunofluorescence findings.Anais brasileiros de dermatologiaArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionVasculitides are a heterogeneous group of diseases characterized by inflammation of the blood vessel walls. Etiological factors include infections, drugs, connective tissue diseases, and malignancies.
aimTo examine the demographic characteristics, etiological factors, and treatment options in 75 patients with leukocytoclastic vasculitis. MATERIAL AND
methodsThe study included 75 patients diagnosed with leukocytoclastic vasculitis at our clinic. The patients' medical records were reviewed to determine their age, sex, presence of systemic symptoms, possible etiological factors, laboratory results, types of cutaneous lesions, locations of the lesions, treatment options, and disease course.
resultsThere were 43 women and 32 men. Cutaneous lesions affected only the lower limbs in 60 of the 75 patients (80%) and usually presented as palpable purpura (64%,
conclusionsThe most common form of vasculitis in our study was cutaneous leukocytoclastic vasculitis. In most of the patients it appeared to be idiopathic. Among drugs, antibiotics were the most common etiological factor. In 4 patients, the cutaneous leukocytoclastic vasculitis behaved like the paraneoplastic syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.